1. O-306 LINZAGOLIX FOR ENDOMETRIOSIS-ASSOCIATED PAIN: SAFETY RESULTS FROM EDELWEISS 3, A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL. (30th June 2022) Authors: Donnez, J; Taylor, H; Gemzell-Danielsson, K; Catherino, W; Bestel, E; Gotteland, J.P; Humberstone, A; Moore, L; Garner, E Journal: Human reproduction Issue: Volume 37(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗